Cadila Pharma’s official meets H. E. Mr. Denis Manturov at India – Russia Business Dialogue

Cadila Pharmaceuticals plans to set up a state-of-the-art pharmaceutical injectable manufacturing facility in collaboration with Russia & bring in affordable healthcare solutions to the US $30 Billion Russian Healthcare market.

Ahmedabad, 21^st April 2023: Cadila Pharmaceuticals Limited met the eminent H. E. Mr. Denis Manturov, Hon’ble Deputy Prime Minister and Minister for Industry & Trade for Russian Federation, and H. E. Dr. S. Jaishankar, Hon’ble External Affairs Minister, Government of India at a high-powered Bilateral Industrial Roundtable “India – Russia Business Dialogue” on 17th April 2023 at New Delhi.

The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries.

On behalf of Cadila Pharmaceuticals, Mr. Raj Prakash Vyas, President – Corporate Affairs met and interacted with Hon’ble Ministers and also joined as a Key Speaker at the Inaugural Session. He conveyed our objective behind collaboration with Russia for setting up State-of-the-Art pharmaceutical injectable manufacturing unit with global compliance and Cadila Pharmaceuticals’ trust and long-standing credibility – thereby contributing towards affordable healthcare solutions to the US$ 30 billion Russian Healthcare market.

The business dialogue was also joined by H.E. Mr. Sergey Cheremin, Chairman of the Board of the Business Council for Cooperation with India and Minister of the Department of Foreign Economic Activity and International Relations, Moscow City Government.

Hon’ble Minister Mr. Cheremin was highly impressed with Cadila Pharma’s motivation of “The Care Continues….” and its mission towards providing affordable healthcare to all by showcasing its innovative research-driven products in various therapeutic areas. Later in the evening, he further invited Cadila Pharma for a one-to-one strategic meeting and shared strategic initiatives of the Moscow Government for Ease of Doing Business. A deep-dive discussion to explore the opportunities for business collaboration and expansion in the area of Pharmaceuticals and Herbal (Ayurveda) Businesses in Moscow, Russia.

About Cadila Pharmaceuticals Limited

Cadila Pharmaceuticals Ltd. is one of India’s leading integrated privately held pharmaceutical firms, located in Ahmedabad, Gujarat. The firm develops and produces pharmaceutical products in India and sells and distributes them in over 100 countries. The organization places a high emphasis and priority on research, whether it is in biotechnology, APIs, formulations, plant tissue culture or phytochemistry to innovate in various therapeutic areas including gastrointestinal, cardiology, pulmonary, oncology, gynaecology, cardiovascular, Diabetology, and osteology. Its undaunted commitment to create affordable miracles in therapeutic areas with significant unmet medical needs to serve the society & community at large, has led to several world-first breakthroughs.